Cardiometabolic risk factors and antithrombotic treatment in a Mexican population with atrial fibrillation and heart failure with reduced ejection fraction.
Baños-González MA, González-Hermosillo A, Guevara-Valdivia ME, Vázquez-Acosta JA, de Los Ríos-Ibarra MO, Aguilar-Linares JA, Cantú-Brito C, Leiva-Pons JL, Pozas-Garza G, Favela-Pérez EA, Molina L, Magaña-Magaña R, Camacho-Casillas R, Chuquiure-Valenzuela E, Manzano-Cabada J, Márquez-Murillo MF.
Baños-González MA, et al. Among authors: gonzalez hermosillo a.
Gac Med Mex. 2023;159(1):24-31. doi: 10.24875/GMM.M22000738.
Gac Med Mex. 2023.
PMID: 36930551
Free article.
English.